Vaxneuvance 0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4F9U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,037
Award facts
- Contract value 100% obligated
- $33,037.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,037.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.5 mL syringes of Vaxneuvance, a pneumococcal vaccine, with an ultimate completion date of January 29, 2026. This non-set-aside contract was awarded competitively on January 28, 2026, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing comprehensive medical product support to federal agencies, particularly the Department of Defense and veterans' healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical commodities, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Vaxneuvance reflects the company's ongoing role in supplying critical immunization products to support military medical readiness and healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F4F9U?
SPE2DR26F4F9U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4F9U worth?
The government has obligated $33,037 on SPE2DR26F4F9U.
Is contract SPE2DR26F4F9U an order under another contract?
Yes. SPE2DR26F4F9U is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F9U competed?
The extent of competition for SPE2DR26F4F9U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award